Insights

June 2022

Seven factors that make a multi-party life sciences consortium more likely to succeed

Drug discovery is inherently a team sport. To increase your business' impact you may well want to enter risk sharing partnerships, consortia, and multi-party relationships that can access different funding sources, and bring you into close working with major industry figures. These take time and effort to make them work.

So - go in with your eyes open, and try to shape that partnership to give it the best chance to succeed:

1) A strong reason for academics to bring their projects into the consortium 

2) Upfront clarity on intellectual property ownership 

3) Agreed data thresholds triggering a project to progress 

4) An Honest Broker to manage the knowledge 

5) Agreed, realistic, long term goals for the consortium 

6) Independent validation of critical data 

7) Serendipity - we all need a bit of luck!

 

Want to find out more about making complex collaborations succeed?

https://www.nature.com/articles/d41573-020-00079-z

And reach out via the Contact us page to discuss how Peter Simpson Consulting Ltd can help

 

 

Interested to know more?

Read our next blog, or contact us for a free discussion on how we can help your business

We need your consent to load the translations

We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.